Skip to main content
PMC home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1990 Dec;28(12):2815–2817. doi: 10.1128/jcm.28.12.2815-2817.1990

Labile type-specific antigen of Moraxella catarrhalis.

S J Norkus 1, J W Vennes 1
PMCID: PMC268283  PMID: 2126268

Abstract

By using hot acid extract and double-diffusion studies, an antigen isolated from clinical strains of Moraxella catarrhalis, designated the C antigen, was studied. The antigen is labile, relatively trypsin insensitive, and either polysaccharide or glycoconjugate in nature. At least two serologically distinct C antigens have been identified.

Full text

PDF
2815

Images in this article

2815Image
on p.2815
2816Image
on p.2816
2816Image
on p.2816
2816Image
on p.2816
2816Image
on p.2816

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brook I. Direct and indirect pathogenicity of Branhamella catarrhalis. Drugs. 1986;31 (Suppl 3):97–102. doi: 10.2165/00003495-198600313-00021. [DOI] [PubMed] [Google Scholar]
  2. Calder M. A., Croughan M. J., McLeod D. T., Ahmad F. The incidence and antibiotic susceptibility of Branhamella catarrhalis in respiratory infections. Drugs. 1986;31 (Suppl 3):11–16. doi: 10.2165/00003495-198600313-00005. [DOI] [PubMed] [Google Scholar]
  3. Chapman A. J., Jr, Musher D. M., Jonsson S., Clarridge J. E., Wallace R. J., Jr Development of bactericidal antibody during Branhamella catarrhalis infection. J Infect Dis. 1985 May;151(5):878–882. doi: 10.1093/infdis/151.5.878. [DOI] [PubMed] [Google Scholar]
  4. Diamond L. A., Lorber B. Branhamella catarrhalis pneumonia and immunoglobulin abnormalities: a new association. Am Rev Respir Dis. 1984 May;129(5):876–878. doi: 10.1164/arrd.1984.129.5.876. [DOI] [PubMed] [Google Scholar]
  5. Doern G. V., Morse S. A. Branhamella (Neisseria) catarrhalis: criteria for laboratory identification. J Clin Microbiol. 1980 Feb;11(2):193–195. doi: 10.1128/jcm.11.2.193-195.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Eliasson I. A protein antigen characteristic of Branhamella catarrhalis. Serological identification of the genus. Acta Pathol Microbiol Scand B. 1980 Oct;88(5):281–286. doi: 10.1111/j.1699-0463.1980.tb02642.x. [DOI] [PubMed] [Google Scholar]
  7. Eliasson I. Serological identification of Branhamella catarrhalis. Serological evidence for infection. Drugs. 1986;31 (Suppl 3):7–10. doi: 10.2165/00003495-198600313-00004. [DOI] [PubMed] [Google Scholar]
  8. Johnson M. A., Drew W. L., Roberts M. Branhamella (Neisseria) catarrhalis--a lower respiratory tract pathogen? J Clin Microbiol. 1981 Jun;13(6):1066–1069. doi: 10.1128/jcm.13.6.1066-1069.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Malkamäki M., Honkanen E., Leinonen M., Mäkelä P. H. Branhamella catarrhalis as a cause of bacteremic pneumonia. Scand J Infect Dis. 1983;15(1):125–126. doi: 10.3109/inf.1983.15.issue-1.21. [DOI] [PubMed] [Google Scholar]
  10. McLeod D. T., Ahmad F., Calder M. A. Infection and Branhamella catarrhalis. Biomed Pharmacother. 1985;39(4):170–173. [PubMed] [Google Scholar]
  11. McLeod D. T., Ahmad F., Capewell S., Croughan M. J., Calder M. A., Seaton A. Increase in bronchopulmonary infection due to branhamella catarrhalis. Br Med J (Clin Res Ed) 1986 Apr 26;292(6528):1103–1105. doi: 10.1136/bmj.292.6528.1103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Patterson T. F., Patterson J. E., Masecar B. L., Barden G. E., Hierholzer W. J., Jr, Zervos M. J. A nosocomial outbreak of Branhamella catarrhalis confirmed by restriction endonuclease analysis. J Infect Dis. 1988 May;157(5):996–1001. doi: 10.1093/infdis/157.5.996. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES